CYTOGEN’s ONCOSCINT RECEIVES ADVISORY COMMITTEE CLEARANCE FOR DIAGNOSIS OF OVARIAN AND COLORECTAL CANCER; MAY BE FIRST MAb-BASED TUMOR IMAGING AGENT

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".